Mr Andrew Sewalish, PA-C | |
3623 Latrobe Dr Ste 216, Charlotte, NC 28211 | |
(704) 332-1291 | |
(704) 332-5206 |
Full Name | Mr Andrew Sewalish |
---|---|
Gender | Male |
Speciality | Physician Assistant |
Experience | 10 Years |
Location | 3623 Latrobe Dr Ste 216, Charlotte, North Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023407384 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0204X | Radiology - Vascular & Interventional Radiology | 0010-05477 (North Carolina) | Secondary |
363A00000X | Physician Assistant | 0010-05477 (North Carolina) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Novant Health Rowan Medical Center | Salisbury, NC | Hospital |
Novant Health Huntersville Medical Center | Huntersville, NC | Hospital |
Lake Norman Regional Medical Center | Mooresville, NC | Hospital |
Novant Health Presbyterian Medical Center | Charlotte, NC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mecklenburg Radiology Associates Pa | 6800789587 | 77 |
News Archive
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, and its partner Newron Pharmaceuticals SpA has announced that the first Phase III trial of investigational agent safinamide as adjunctive therapy to levodopa (study 016) met its primary endpoint by increasing daily "ON" time in mid- to late-stage Parkinson's disease patients with motor fluctuations by 1.3 hours.
The U.S. Food and Drug Administration (FDA) this Wednesday approved the sale of Edwards Life Sciences Corp's Sapien heart valve for patients deemed too sick to have open-heart surgery.
The year 2010 marks a significant date in the history of the University of Kentucky College of Medicine as it celebrates its 50th anniversary. The festivities culminate on Oct. 15 with the Signature Event, held at the Keeneland Sales Pavilion. This year commemorates individuals who have been a part of the accomplishments of the past five decades and for those who will be a part of its bright future.
GE Healthcare will today present results from its multicenter phase 2 study of flutemetamol at the 4th annual Human Amyloid Imaging Meeting in Toronto, Canada. Flutemetamol is a positron emission tomography imaging agent in development by GE Healthcare, in the field of brain imaging.
The Texas Center for Quality & Patient Safety announced today that Blue Cross and Blue Shield of Texas is continuing its support for the TCQPS with a $150,000 donation to study and improve patient safety, including reduction of hospital readmissions and hospital-acquired infections.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Mr Andrew Sewalish, PA-C Po Box 221249, Charlotte, NC 28222-1249 Ph: (704) 332-1291 | Mr Andrew Sewalish, PA-C 3623 Latrobe Dr Ste 216, Charlotte, NC 28211 Ph: (704) 332-1291 |
News Archive
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, and its partner Newron Pharmaceuticals SpA has announced that the first Phase III trial of investigational agent safinamide as adjunctive therapy to levodopa (study 016) met its primary endpoint by increasing daily "ON" time in mid- to late-stage Parkinson's disease patients with motor fluctuations by 1.3 hours.
The U.S. Food and Drug Administration (FDA) this Wednesday approved the sale of Edwards Life Sciences Corp's Sapien heart valve for patients deemed too sick to have open-heart surgery.
The year 2010 marks a significant date in the history of the University of Kentucky College of Medicine as it celebrates its 50th anniversary. The festivities culminate on Oct. 15 with the Signature Event, held at the Keeneland Sales Pavilion. This year commemorates individuals who have been a part of the accomplishments of the past five decades and for those who will be a part of its bright future.
GE Healthcare will today present results from its multicenter phase 2 study of flutemetamol at the 4th annual Human Amyloid Imaging Meeting in Toronto, Canada. Flutemetamol is a positron emission tomography imaging agent in development by GE Healthcare, in the field of brain imaging.
The Texas Center for Quality & Patient Safety announced today that Blue Cross and Blue Shield of Texas is continuing its support for the TCQPS with a $150,000 donation to study and improve patient safety, including reduction of hospital readmissions and hospital-acquired infections.
› Verified 7 days ago